{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:23:55Z","timestamp":1787167435894,"version":"build-2736575974"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021855","name":"University of Ioannina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Obesity is a major global health crisis with rising prevalence in both pediatric and adult populations, leading to an increased risk of cardiovascular, metabolic, and other chronic complications affecting all organ systems. A clear understanding of the genetic contributors to polygenic, syndromic, and monogenic obesity is essential for early diagnosis and targeted management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Advances in genome-wide association studies (GWAS) and sequencing technologies have greatly expanded our understanding of the genetic alterations underlying this multifaceted disease and have helped in delivering personalized treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The pathogenesis of common, polygenic obesity is related to a complex interplay between genetic susceptibility and environmental factors. Syndromic obesity, a less common form, is characterized by early-onset accompanied by additional features such as developmental delay, dysmorphic traits, and various organ system involvement. The rarest form, monogenic obesity, is characterized by severe early-onset non-syndromic obesity caused by mutations in single genes regulating appetite within the hypothalamus. These monogenic obesity cases, though infrequent, have been instrumental in elucidating key pathways involved in hunger and satiety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review provides a comprehensive summary of the most recent findings on the genetic basis of obesity across all age groups, highlighting clinical implications and emerging therapeutic opportunities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-026-04696-3","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:29:18Z","timestamp":1783924158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic determinants of obesity: mechanisms, clinical implications, and targeted therapies"],"prefix":"10.1007","volume":"91","author":[{"given":"Anastasios","family":"Serbis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Kantza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Garoufou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterini","family":"Siomou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Tigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"4696_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NH Phelps","year":"2024","unstructured":"N.H. Phelps, R.K. Singleton, B. Zhou, R.A. Heap, A. Mishra et al., Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 403, 1027\u20131050 (2024). https:\/\/doi.org\/10.1016\/S0140-6736(23)02750-2","journal-title":"Lancet"},{"key":"4696_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1056\/NEJM198601233140401","volume":"314","author":"AJ Stunkard","year":"1986","unstructured":"A.J. Stunkard, T.I.A. S\u00f8rensen, C. Hanis, T.W. Teasdale, R. Chakraborty et al., An Adoption Study of Human Obesity. N Engl. J. Med. 314, 193\u2013198 (1986). https:\/\/doi.org\/10.1056\/NEJM198601233140401","journal-title":"N Engl. J. Med."},{"key":"4696_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ijo.2009.177","volume":"34","author":"K Silventoinen","year":"2010","unstructured":"K. Silventoinen, B. Rokholm, J. Kaprio, S\u00f8rensen, T.I.A. The genetic and environmental influences on childhood obesity: A systematic review of twin and adoption studies. Int. J. Obes. 34, 29\u201340 (2010). https:\/\/doi.org\/10.1038\/ijo.2009.177","journal-title":"Int. J. Obes."},{"key":"4696_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fendo.2012.00029","volume":"3","author":"CE Elks","year":"2012","unstructured":"C.E. Elks, den M. Hoed, J.H. Zhao, S.J. Sharp, N.J. Wareham et al., Variability in the Heritability of Body Mass Index: A Systematic Review and Meta-Regression. Front. Endocrinol. (Lausanne). 3, 29 (2012). https:\/\/doi.org\/10.3389\/fendo.2012.00029","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4696_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","volume":"23","author":"RJF Loos","year":"2022","unstructured":"R.J.F. Loos, G.S.H. Yeo, The genetics of obesity: from discovery to biology. Nat. Rev. Genet. 23, 120\u2013133 (2022). https:\/\/doi.org\/10.1038\/s41576-021-00414-z","journal-title":"Nat. Rev. Genet."},{"key":"4696_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/oby.23116","volume":"29","author":"C Bouchard","year":"2021","unstructured":"C. Bouchard, Genetics of Obesity: What We Have Learned Over Decades of Research. Obesity. 29, 802\u2013820 (2021). https:\/\/doi.org\/10.1002\/oby.23116","journal-title":"Obesity"},{"key":"4696_CR7","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/s41366-021-00795-5","volume":"45","author":"A H\u00fcls","year":"2021","unstructured":"A. H\u00fcls, M.N. Wright, L.H. Bogl, J. Kaprio, L. Lissner et al., Polygenic risk for obesity and its interaction with lifestyle and sociodemographic factors in European children and adolescents. Int. J. Obes. 45, 1321\u20131330 (2021). https:\/\/doi.org\/10.1038\/s41366-021-00795-5","journal-title":"Int. J. Obes."},{"key":"4696_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13679-023-00543-y","volume":"13","author":"LML Carvalho","year":"2024","unstructured":"L.M.L. Carvalho, A.A.L. Jorge, D.R. Bertola, A.C.V. Krepischi, C. Rosenberg, A Comprehensive Review of Syndromic Forms of Obesity: Genetic Etiology, Clinical Features and Molecular Diagnosis. Curr. Obes. Rep. 13, 313\u2013337 (2024). https:\/\/doi.org\/10.1007\/s13679-023-00543-y","journal-title":"Curr. Obes. Rep."},{"key":"4696_CR9","doi-asserted-by":"publisher","first-page":"100110","DOI":"10.1016\/j.obpill.2024.100110","volume":"11","author":"AK Fitch","year":"2024","unstructured":"A.K. Fitch, S. Malhotra, R. Conroy, Differentiating monogenic and syndromic obesities from polygenic obesity: Assessment, diagnosis, and management. Obes. Pillars. 11, 100110 (2024). https:\/\/doi.org\/10.1016\/j.obpill.2024.100110","journal-title":"Obes. Pillars"},{"key":"4696_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.15765","volume":"165","author":"O Lavoie","year":"2023","unstructured":"O. Lavoie, M.N.J. Caron, A critical update on the leptin-melanocortin system. J. Neurochem. 165, 467\u2013486 (2023). https:\/\/doi.org\/10.1111\/jnc.15765","journal-title":"J. Neurochem"},{"key":"4696_CR11","doi-asserted-by":"publisher","first-page":"101206","DOI":"10.1016\/j.molmet.2021.101206","volume":"48","author":"GSH Yeo","year":"2021","unstructured":"G.S.H. Yeo, D.H.M. Chao, A.M. Siegert, Z.M. Koerperich, M.D. Ericson et al., The melanocortin pathway and energy homeostasis: From discovery to obesity therapy. Mol. Metab. 48, 101206 (2021). https:\/\/doi.org\/10.1016\/j.molmet.2021.101206","journal-title":"Mol. Metab."},{"key":"4696_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.gtc.2023.08.005","volume":"52","author":"JC Han","year":"2023","unstructured":"J.C. Han, M.C. Rasmussen, A.R. Forte, S.B. Schrage, S.K. Zafar et al., Management of Monogenic and Syndromic Obesity. Gastroenterol. Clin. North. Am. 52, 733\u2013750 (2023). https:\/\/doi.org\/10.1016\/j.gtc.2023.08.005","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"4696_CR13","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"L. Yengo, J. Sidorenko, K.E. Kemper, Z. Zheng, A.R. Wood et al., Meta-analysis of genome-wide association studies for height and body mass index in ~\u2009700 000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641\u20133649 (2018). https:\/\/doi.org\/10.1093\/hmg\/ddy271","journal-title":"Hum. Mol. Genet."},{"key":"4696_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/hmg\/ddy327","volume":"28","author":"SL Pulit","year":"2019","unstructured":"S.L. Pulit, C. Stoneman, A.P. Morris, A.R. Wood, C.A. Glastonbury et al., Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum. Mol. Genet. 28, 166\u2013174 (2019). https:\/\/doi.org\/10.1093\/hmg\/ddy327","journal-title":"Hum. Mol. Genet."},{"key":"4696_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"A.E. Locke, B. Kahali, S.I. Berndt, A.E. Justice, T.H. Pers et al., Genetic studies of body mass index yield new insights for obesity biology. Nature. 518, 197\u2013206 (2015). https:\/\/doi.org\/10.1038\/nature14177","journal-title":"Nature"},{"key":"4696_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.1141634","volume":"316","author":"TM Frayling","year":"2007","unstructured":"T.M. Frayling, N.J. Timpson, M.N. Weedon, E. Zeggini, R.M. Freathy et al., A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 316, 889\u2013894 (2007). https:\/\/doi.org\/10.1126\/science.1141634","journal-title":"Science"},{"key":"4696_CR17","doi-asserted-by":"publisher","first-page":"100832","DOI":"10.1016\/j.mgene.2020.100832","volume":"27","author":"AHA Ali","year":"2021","unstructured":"A.H.A. Ali, T.P. Shkurat, A.H. Abbas, Association analysis of FTO gene polymorphisms rs9939609 and obesity risk among the adults: A systematic review and meta-analysis. Meta Gene. 27, 100832 (2021). https:\/\/doi.org\/10.1016\/j.mgene.2020.100832","journal-title":"Meta Gene"},{"key":"4696_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-77004-6","volume":"1","author":"S Poosri","year":"2024","unstructured":"S. Poosri, U. Boonyuen, C. Chupeerach, N. Soonthornworasiri, K. Kwanbunjan et al., Association of FTO variants rs9939609 and rs1421085 with elevated sugar and fat consumption in adult obesity. Sci. Rep. 1, 1\u201315 (2024). https:\/\/doi.org\/10.1038\/s41598-024-77004-6","journal-title":"Sci. Rep."},{"key":"4696_CR19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.140","volume":"40","author":"RJF Loos","year":"2008","unstructured":"R.J.F. Loos, C.M. Lindgren, S. Li, E. Wheeler, J. Hua Zhao et al., Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 40, 768\u2013775 (2008). https:\/\/doi.org\/10.1038\/ng.140","journal-title":"Nat. Genet."},{"key":"4696_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.274","volume":"41","author":"G Thorleifsson","year":"2009","unstructured":"G. Thorleifsson, G.B. Walters, D.F. Gudbjartsson, V. Steinthorsdottir, P. Sulem et al., Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41, 18\u201324 (2009). https:\/\/doi.org\/10.1038\/ng.274","journal-title":"Nat. Genet."},{"key":"4696_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000368425","volume":"66","author":"ML Mansego","year":"2015","unstructured":"M.L. Mansego, F.I. Milagro, M.A. Zulet, J.A. Martinez, SH2B1 CpG-SNP Is Associated with Body Weight Reduction in Obese Subjects Following a Dietary Restriction Program. Ann. Nutr. Metab. 66, 1\u20139 (2015). https:\/\/doi.org\/10.1159\/000368425","journal-title":"Ann. Nutr. Metab."},{"key":"4696_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s13679-023-00526-z","volume":"12","author":"M Keller","year":"2023","unstructured":"M. Keller, S.I.A. Svensson, K. Rohde-Zimmermann, P. Kovacs, Y. B\u00f6ttcher, Genetics and Epigenetics in Obesity: What Do We Know so Far? Curr. Obes. Rep. 12, 482\u2013493 (2023). https:\/\/doi.org\/10.1007\/s13679-023-00526-z","journal-title":"Curr. Obes. Rep."},{"key":"4696_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s11154-023-09804-6","volume":"24","author":"K Trang","year":"2023","unstructured":"K. Trang, S.F.A. Grant, Genetics and epigenetics in the obesity phenotyping scenario. Rev. Endocr. Metab. Disord. 24, 881\u2013891 (2023). https:\/\/doi.org\/10.1007\/s11154-023-09804-6","journal-title":"Rev. Endocr. Metab. Disord"},{"key":"4696_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2019.03.028","volume":"177","author":"AV Khera","year":"2019","unstructured":"A.V. Khera, M. Chaffin, K.H. Wade, S. Zahid, J. Brancale et al., Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood. Cell. 177, 587\u2013596 (2019). https:\/\/doi.org\/10.1016\/j.cell.2019.03.028","journal-title":"Cell"},{"key":"4696_CR25","doi-asserted-by":"publisher","first-page":"e13810","DOI":"10.1111\/obr.13810","volume":"25","author":"PR Jansen","year":"2024","unstructured":"P.R. Jansen, N. Vos, van J. Uhm, I.A. Dekkers, van der R. Meer et al., The utility of obesity polygenic risk scores from research to clinical practice: A review. Obes. Rev. 25, e13810 (2024). https:\/\/doi.org\/10.1111\/obr.13810","journal-title":"Obes. Rev."},{"key":"4696_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14132","volume":"518","author":"D Shungin","year":"2015","unstructured":"D. Shungin, T. Winkler, D.C. Croteau-Chonka, T. Ferreira, A.E. Locke et al., New genetic loci link adipose and insulin biology to body fat distribution. Nature. 518, 187\u2013196 (2015). https:\/\/doi.org\/10.1038\/nature14132","journal-title":"Nature"},{"key":"4696_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41467-018-08000-4","volume":"10","author":"M Rask-Andersen","year":"2019","unstructured":"M. Rask-Andersen, T. Karlsson, W.E. Ek, \u00c5. Johansson, Genome-wide association study of body fat distribution identifies adiposity loci and sex-specific genetic effects. Nat. Commun. 10, 339 (2019). https:\/\/doi.org\/10.1038\/s41467-018-08000-4","journal-title":"Nat. Commun."},{"key":"4696_CR28","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ng.685","volume":"42","author":"IM Heid","year":"2010","unstructured":"I.M. Heid, A.U. Jackson, J.C. Randall, T.W. Winkler, L. Qi et al., Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42, 949\u2013960 (2010). https:\/\/doi.org\/10.1038\/ng.685","journal-title":"Nat. Genet."},{"key":"4696_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41467-022-35704-5","volume":"14","author":"S Agrawal","year":"2023","unstructured":"S. Agrawal, M.D.R. Klarqvist, N. Diamant, T.L. Stanley, P.T. Ellinor et al., BMI-adjusted adipose tissue volumes exhibit depot-specific and divergent associations with cardiometabolic diseases. Nat. Commun. 14, 266 (2023). https:\/\/doi.org\/10.1038\/s41467-022-35704-5","journal-title":"Nat. Commun."},{"key":"4696_CR30","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1194\/jlr.R086975","volume":"60","author":"AP Frank","year":"2019","unstructured":"A.P. Frank, De R. Souza Santos, B.F. Palmer, D.J. Clegg, Determinants of body fat distribution in humans may provide insight about obesity-related health risks. J. Lipid Res. 60, 1710\u20131719 (2019). https:\/\/doi.org\/10.1194\/jlr.R086975","journal-title":"J. Lipid Res."},{"key":"4696_CR31","doi-asserted-by":"publisher","first-page":"100362","DOI":"10.1016\/j.xgen.2023.100362","volume":"3","author":"LR Kaisinger","year":"2023","unstructured":"L.R. Kaisinger, K.A. Kentistou, S. Stankovic, E.J. Gardner, F.R. Day et al., Large-scale exome sequence analysis identifies sex- and age-specific determinants of obesity. Cell. Genomics. 3, 100362 (2023). https:\/\/doi.org\/10.1016\/j.xgen.2023.100362","journal-title":"Cell. Genomics"},{"key":"4696_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10654-019-00502-9","volume":"34","author":"CM Middeldorp","year":"2019","unstructured":"C.M. Middeldorp, J.F. Felix, A. Mahajan, M.I. McCarthy, The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects. Eur. J. Epidemiol. 34, 279\u2013289 (2019). https:\/\/doi.org\/10.1007\/s10654-019-00502-9","journal-title":"Eur. J. Epidemiol."},{"key":"4696_CR33","doi-asserted-by":"publisher","first-page":"100411","DOI":"10.1016\/j.xhgg.2025.100411","volume":"6","author":"CG Downie","year":"2025","unstructured":"C.G. Downie, P. Shrestha, S. Okello, M. Yaser, H.H. Lee et al., Trans-ancestry genome-wide association study of childhood body mass index identifies novel loci and age-specific effects. HGG Adv. 6, 100411 (2025). https:\/\/doi.org\/10.1016\/j.xhgg.2025.100411","journal-title":"HGG Adv."},{"key":"4696_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000445061","volume":"9","author":"H Huvenne","year":"2016","unstructured":"H. Huvenne, B. Dubern, K. Cl\u00e9ment, C. Poitou, Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016. Obes. Facts. 9, 158\u2013173 (2016). https:\/\/doi.org\/10.1159\/000445061","journal-title":"Obes. Facts"},{"key":"4696_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/obr.12531","volume":"18","author":"Y Kaur","year":"2017","unstructured":"Y. Kaur, de R.J. Souza, W.T. Gibson, D. Meyre, A systematic review of genetic syndromes with obesity. Obes. Rev. 18, 603\u2013634 (2017). https:\/\/doi.org\/10.1111\/obr.12531","journal-title":"Obes. Rev."},{"key":"4696_CR36","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41366-022-01139-7","volume":"46","author":"KJ Roberts","year":"2022","unstructured":"K.J. Roberts, A.J. Ariza, K. Selvaraj, M. Quadri, C. Mangarelli et al., Testing for rare genetic causes of obesity: findings and experiences from a pediatric weight management program. Int. J. Obes. 46, 1493\u20131501 (2022). https:\/\/doi.org\/10.1038\/s41366-022-01139-7","journal-title":"Int. J. Obes."},{"key":"4696_CR37","doi-asserted-by":"publisher","first-page":"1509994","DOI":"10.3389\/fnut.2024.1509994","volume":"11","author":"TH Collet","year":"2024","unstructured":"T.H. Collet, V. Schwitzgebel, Exploring the therapeutic potential of precision medicine in rare genetic obesity disorders: a scientific perspective. Front. Nutr. 11, 1509994 (2024). https:\/\/doi.org\/10.3389\/fnut.2024.1509994","journal-title":"Front. Nutr."},{"key":"4696_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4274\/jcrpe.galenos.2023.2023-3-2","volume":"15","author":"N Faccioli","year":"2023","unstructured":"N. Faccioli, C. Poitou, K. Cl\u00e9ment, B. Dubern, Current Treatments for Patients with Genetic Obesity. J. Clin. Res. Pediatr. Endocrinol. 15, 108\u2013119 (2023). https:\/\/doi.org\/10.4274\/jcrpe.galenos.2023.2023-3-2","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"4696_CR39","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","volume":"38","author":"MA Angulo","year":"2015","unstructured":"M.A. Angulo, M.G. Butler, M.E. Cataletto, Prader-Willi syndrome: A review of clinical, genetic, and endocrine findings. J. Endocrinol. Invest. 38, 1249\u20131263 (2015). https:\/\/doi.org\/10.1007\/s40618-015-0312-9","journal-title":"J. Endocrinol. Invest."},{"key":"4696_CR40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1440-1754.2011.02225.x","volume":"48","author":"T Lionti","year":"2012","unstructured":"T. Lionti, S.M. Reid, M.M. Rowell, Prader-Willi syndrome in Victoria: mortality and causes of death. J. Paediatr. Child. Health. 48, 506\u2013511 (2012). https:\/\/doi.org\/10.1111\/j.1440-1754.2011.02225.x","journal-title":"J. Paediatr. Child. Health"},{"key":"4696_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"S.B. Cassidy, S. Schwartz, J.L. Miller, D.J. Driscoll, Prader-Willi syndrome. Genet. Med. 14, 10\u201326 (2012). https:\/\/doi.org\/10.1038\/gim.0b013e31822bead0","journal-title":"Genet. Med."},{"key":"4696_CR42","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","volume":"155","author":"JL Miller","year":"2011","unstructured":"J.L. Miller, C.H. Lynn, D.C. Driscoll, A.P. Goldstone, J.A. Gold et al., Nutritional phases in Prader-Willi syndrome. Am. J. Med. Genet. A 155, 1040\u20131049 (2011). https:\/\/doi.org\/10.1002\/ajmg.a.33951","journal-title":"Am. J. Med. Genet. A"},{"key":"4696_CR43","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.1210\/jc.2002-020871","volume":"87","author":"A Delparigi","year":"2002","unstructured":"A. Delparigi, M. Tsch\u00f6p, M.L. Heiman, A.D. Salbe, B. Vozarova et al., High circulating ghrelin: A potential cause for hyperphagia and obesity in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 87, 5461\u20135464 (2002). https:\/\/doi.org\/10.1210\/jc.2002-020871","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4696_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.6065\/apem.2142164.082","volume":"26","author":"SJ Kim","year":"2021","unstructured":"S.J. Kim, S.Y. Cho, D.K. Jin, Prader-Willi syndrome: an update on obesity and endocrine problems. Ann. Pediatr. Endocrinol. Metab. 26, 227\u2013236 (2021). https:\/\/doi.org\/10.6065\/apem.2142164.082","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"4696_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.21037\/tp.2017.09.04","volume":"6","author":"R Heksch","year":"2017","unstructured":"R. Heksch, M. Kamboj, K. Anglin, K. Obrynba, Review of Prader-Willi syndrome: the endocrine approach. Transl Pediatr. 6, 274\u2013285 (2017). https:\/\/doi.org\/10.21037\/tp.2017.09.04","journal-title":"Transl Pediatr."},{"key":"4696_CR46","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.12771\/emj.2023.e33","volume":"46","author":"YB Sohn","year":"2023","unstructured":"Y.B. Sohn, J.E. Moon, Y.J. Jung, Y.A. Yu, Updates on Obesity in Prader-Willi Syndrome: From Genetics to Management. Ewha Med. J. 46, e33 (2023). https:\/\/doi.org\/10.12771\/emj.2023.e33","journal-title":"Ewha Med. J."},{"key":"4696_CR47","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.2012-3888","volume":"98","author":"CL Deal","year":"2013","unstructured":"C.L. Deal, M. Tony, C. H\u00f6ybye, D.B. Allen, M. Tauber et al., Growth hormone research society workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 98, 1072\u20131087 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3888","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4696_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13023-019-1195-1","volume":"14","author":"A Yang","year":"2019","unstructured":"A. Yang, J.H. Choi, Y.B. Sohn, Y. Eom, J. Lee et al., Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: A randomized, active-controlled trial. Orphanet J. Rare Dis. 14, 216 (2019). https:\/\/doi.org\/10.1186\/s13023-019-1195-1","journal-title":"Orphanet J. Rare Dis."},{"key":"4696_CR49","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3390\/ijms24032150","volume":"24","author":"R Mahmoud","year":"2023","unstructured":"R. Mahmoud, V. Kimonis, M.G. Butler, Clinical Trials in Prader\u2013Willi Syndrome: A Review. Int. J. Mol. Sci. 24, 2150 (2023). https:\/\/doi.org\/10.3390\/ijms24032150","journal-title":"Int. J. Mol. Sci."},{"key":"4696_CR50","doi-asserted-by":"publisher","unstructured":"\u00c9. Erhardt, D. Moln\u00e1r, Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment. Nutrients. 14, 1950 (2022). https:\/\/doi.org\/10.3390\/nu14091950","DOI":"10.3390\/nu14091950"},{"key":"4696_CR51","doi-asserted-by":"publisher","first-page":"1528457","DOI":"10.3389\/fendo.2024.1528457","volume":"15","author":"A Koceva","year":"2025","unstructured":"A. Koceva, K. Mleku\u0161 Kozamernik, A. Jane\u017e, R. Herman, S. Ferjan et al., Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review. Front. Endocrinol. (Lausanne). 15, 1528457 (2025). https:\/\/doi.org\/10.3389\/fendo.2024.1528457","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4696_CR52","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/ijpo.12131","volume":"12","author":"P Salehi","year":"2017","unstructured":"P. Salehi, I. Hsu, C.G. Azen, S.D. Mittelman, M.E. Geffner et al., Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome. Pediatr. Obes. 12, 221\u2013228 (2017). https:\/\/doi.org\/10.1111\/ijpo.12131","journal-title":"Pediatr. Obes."},{"key":"4696_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/clinem\/dgac549","volume":"108","author":"G Diene","year":"2022","unstructured":"G. Diene, M. Angulo, P.M. Hale, C.H. Jepsen, P.L. Hofman et al., Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity. J. Clin. Endocrinol. Metab. 108, 4\u201312 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgac549","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4696_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/cen.14583","volume":"96","author":"NBH Ng","year":"2022","unstructured":"N.B.H. Ng, Y.W. Low, D.D. Rajgor, J.M. Low, Y.Y. Lim et al., The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review. Clin. Endocrinol. (Oxf). 96, 144\u2013154 (2022). https:\/\/doi.org\/10.1111\/cen.14583","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4696_CR55","doi-asserted-by":"publisher","first-page":"e0221615","DOI":"10.1371\/journal.pone.0221615","volume":"14","author":"V Kimonis","year":"2019","unstructured":"V. Kimonis, A. Surampalli, M. Wencel, J.A. Gold, N.M. Cowen, A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome. PLoS One. 14, e0221615 (2019). https:\/\/doi.org\/10.1371\/journal.pone.0221615","journal-title":"PLoS One"},{"key":"4696_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/oby.23928","volume":"32","author":"JL Miller","year":"2024","unstructured":"J.L. Miller, E. Gevers, N. Bridges, J.A. Yanovski, P. Salehi et al., Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study. Obes. (Silver Spring). 32, 252\u2013261 (2024). https:\/\/doi.org\/10.1002\/oby.23928","journal-title":"Obes. (Silver Spring)"},{"key":"4696_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s11689-024-09536-x","volume":"16","author":"TV Strong","year":"2024","unstructured":"T.V. Strong, J.L. Miller, S.E. McCandless, E. Gevers, J.A. Yanovski et al., Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study. J. Neurodev Disord. 16, 22 (2024). https:\/\/doi.org\/10.1186\/s11689-024-09536-x","journal-title":"J. Neurodev Disord"},{"key":"4696_CR58","doi-asserted-by":"publisher","unstructured":"Diazoxide, choline (Vykat XR) for Prader-Willi syndrome-associated hyperphagia. Med Lett Drugs Ther. 67, 72\u201373 (2025). https:\/\/doi.org\/10.58347\/tml.2025.1727e","DOI":"10.58347\/tml.2025.1727e"},{"key":"4696_CR59","doi-asserted-by":"publisher","first-page":"bvaf149087","DOI":"10.1210\/jendso\/bvaf149.087","volume":"9","author":"AH Shoemaker","year":"2025","unstructured":"A.H. Shoemaker, J.A. Yanovski, E.F. Gevers, K.S. Obrynba, M.D. Lah et al., OR35-07 The Glycemic Outcomes of Diazoxide Choline Extended-Release (DCCR) Tablets for Administered for Hyperphagia in Individuals with Prader-Willi Syndrome Over 4 Years. J. Endocr. Soc. 9, bvaf149087 (2025). https:\/\/doi.org\/10.1210\/jendso\/bvaf149.087","journal-title":"J. Endocr. Soc."},{"key":"4696_CR60","doi-asserted-by":"publisher","first-page":"e12992","DOI":"10.1111\/obr.12992","volume":"21","author":"Q Tan","year":"2020","unstructured":"Q. Tan, C.E. Orsso, E.C. Deehan, L. Triador, C.J. Field et al., Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review. Obes. Rev. 21, e12992 (2020). https:\/\/doi.org\/10.1111\/obr.12992","journal-title":"Obes. Rev."},{"key":"4696_CR61","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/s41431-024-01634-7","volume":"32","author":"H Dollfus","year":"2024","unstructured":"H. Dollfus, M.R. Lilien, P. Maffei, A. Verloes, J. Muller et al., Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations. Eur. J. Hum. Genet. 32, 1347\u20131360 (2024). https:\/\/doi.org\/10.1038\/s41431-024-01634-7","journal-title":"Eur. J. Hum. Genet."},{"key":"4696_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ejhg.2012.115","volume":"21","author":"E Forsythe","year":"2013","unstructured":"E. Forsythe, P.L. Beales, Bardet-Biedl syndrome. Eur. J. Hum. Genet. 21, 8\u201313 (2013). https:\/\/doi.org\/10.1038\/ejhg.2012.115","journal-title":"Eur. J. Hum. Genet."},{"key":"4696_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/dom.15494","volume":"26","author":"A Shoemaker","year":"2024","unstructured":"A. Shoemaker, Bardet-Biedl syndrome: A clinical overview focusing on diagnosis, outcomes and best-practice management. Diabetes Obes. Metab. 26, 25\u201333 (2024). https:\/\/doi.org\/10.1111\/dom.15494","journal-title":"Diabetes Obes. Metab."},{"key":"4696_CR64","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/jmedgenet-2015-103099","volume":"52","author":"S Castro-S\u00e1nchez","year":"2015","unstructured":"S. Castro-S\u00e1nchez, M. \u00c1lvarez-Satta, M. Cort\u00f3n, E. Guill\u00e9n, C. Ayuso et al., Exploring genotype-phenotype relationships in Bardet-Biedl syndrome families. J. Med. Genet. 52, 503\u2013513 (2015). https:\/\/doi.org\/10.1136\/jmedgenet-2015-103099","journal-title":"J. Med. Genet."},{"key":"4696_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcdb.2020.05.006","volume":"110","author":"SE Engle","year":"2021","unstructured":"S.E. Engle, R. Bansal, P.J. Antonellis, N.F. Berbari, Cilia signaling and obesity. Semin Cell. Dev. Biol. 110, 43\u201350 (2021). https:\/\/doi.org\/10.1016\/j.semcdb.2020.05.006","journal-title":"Semin Cell. Dev. Biol."},{"key":"4696_CR66","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","volume":"10","author":"AM Haqq","year":"2022","unstructured":"A.M. Haqq, W.K. Chung, H. Dollfus, R.M. Haws, G. Martos-Moreno et al., Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period. Lancet Diabetes Endocrinol. 10, 859\u2013868 (2022). https:\/\/doi.org\/10.1016\/S2213-8587(22)00277-7","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4696_CR67","doi-asserted-by":"publisher","first-page":"luaf266","DOI":"10.1210\/jcemcr\/luaf266","volume":"3","author":"H Dauleh","year":"2025","unstructured":"H. Dauleh, I. Mohammed, K. Hussain, Efficacy of Semaglutide in Pediatric Patients With Bardet-Biedl Syndrome and Alstr\u00f6m Syndrome. JCEM Case Rep. 3, luaf266 (2025). https:\/\/doi.org\/10.1210\/jcemcr\/luaf266","journal-title":"JCEM Case Rep."},{"key":"4696_CR68","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2337\/diabetes.54.5.1581","volume":"54","author":"T Hearn","year":"2005","unstructured":"T. Hearn, C. Spalluto, V.J. Phillips, G.L. Renforth, N. Copin et al., Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes. 54, 1581\u20131587 (2005). https:\/\/doi.org\/10.2337\/diabetes.54.5.1581","journal-title":"Diabetes"},{"key":"4696_CR69","doi-asserted-by":"publisher","unstructured":"C. Vaisse, J.F. Reiter, N.F. Berbari, Cilia and Obesity. Cold Spring Harb Perspect Biol. 9, a028217 (2017). https:\/\/doi.org\/10.1101\/cshperspect.a028217","DOI":"10.1101\/cshperspect.a028217"},{"key":"4696_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/138920211795677912","volume":"12","author":"D Marshall","year":"2012","unstructured":"D. Marshall, J. Maffei, P.B. Collin, G.K. Naggert, Alstrom Syndrome: Genetics and Clinical Overview. Curr. Genomics. 12, 225\u2013235 (2012). https:\/\/doi.org\/10.2174\/138920211795677912","journal-title":"Curr. Genomics"},{"key":"4696_CR71","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12020-021-02643-y","volume":"71","author":"F Dassie","year":"2021","unstructured":"F. Dassie, F. Favaretto, S. Bettini, M. Parolin, M. Valenti et al., Alstr\u00f6m syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity. Endocrine. 71, 618\u2013625 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02643-y","journal-title":"Endocrine"},{"key":"4696_CR72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13023-020-01468-8","volume":"15","author":"N Tahani","year":"2020","unstructured":"N. Tahani, P. Maffei, H. Dollfus, R. Paisey, D. Valverde et al., Consensus clinical management guidelines for Alstr\u00f6m syndrome. Orphanet J. Rare Dis. 15, 253 (2020). https:\/\/doi.org\/10.1186\/s13023-020-01468-8","journal-title":"Orphanet J. Rare Dis."},{"key":"4696_CR73","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/dom.15398","volume":"26","author":"S Ali","year":"2024","unstructured":"S. Ali, S. Baig, S. Wanninayake, da G. Silva Xavier, C. Dawson et al., Glucagon-like peptide-1 analogues in monogenic syndromic obesity: Real-world data from a large cohort of Alstr\u00f6m syndrome patients. Diabetes Obes. Metab. 26, 989\u2013996 (2024). https:\/\/doi.org\/10.1111\/dom.15398","journal-title":"Diabetes Obes. Metab."},{"key":"4696_CR74","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.gde.2018.02.009","volume":"50","author":"RJ Loos","year":"2018","unstructured":"R.J. Loos, The genetics of adiposity. Curr. Opin. Genet. Dev. 50, 86\u201395 (2018). https:\/\/doi.org\/10.1016\/j.gde.2018.02.009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"4696_CR75","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1210\/er.2006-0040","volume":"27","author":"IS Farooqi","year":"2006","unstructured":"I.S. Farooqi, S. O\u2019Rahilly, Genetics of obesity in humans. Endocr. Rev. 27, 710\u2013718 (2006). https:\/\/doi.org\/10.1210\/er.2006-0040","journal-title":"Endocr. Rev."},{"key":"4696_CR76","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"JM Friedman","year":"1998","unstructured":"J.M. Friedman, J.L. Halaas, Leptin and the regulation of body weight in mammals. Nature. 395, 763\u2013770 (1998). https:\/\/doi.org\/10.1038\/27376","journal-title":"Nature"},{"key":"4696_CR77","doi-asserted-by":"publisher","first-page":"174611","DOI":"10.1016\/j.ejphar.2021.174611","volume":"915","author":"MS Vohra","year":"2022","unstructured":"M.S. Vohra, K. Benchoula, C.J. Serpell, W.E. Hwa, AgRP\/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity. Eur. J. Pharmacol. 915, 174611 (2022). https:\/\/doi.org\/10.1016\/j.ejphar.2021.174611","journal-title":"Eur. J. Pharmacol."},{"key":"4696_CR78","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/aje\/kwi174","volume":"162","author":"V Paracchini","year":"2005","unstructured":"V. Paracchini, P. Pedotti, E. Taioli, Genetics of Leptin and Obesity: A HuGE Review. Am. J. Epidemiol. 162, 101\u2013114 (2005). https:\/\/doi.org\/10.1093\/aje\/kwi174","journal-title":"Am. J. Epidemiol."},{"key":"4696_CR79","doi-asserted-by":"publisher","unstructured":"J.B. Funcke, von J. Schnurbein, B. Lennerz, G. Lahr, K.M. Debatin et al., Monogenic forms of childhood obesity due to mutations in the leptin gene. Mol. Cell. Pediatr. 1 (2014). https:\/\/doi.org\/10.1186\/s40348-014-0003-1","DOI":"10.1186\/s40348-014-0003-1"},{"key":"4696_CR80","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1210\/clinem\/dgae149","volume":"109","author":"J Von Schnurbein","year":"2024","unstructured":"Von J. Schnurbein, S. Zorn, A. Nunziata, S. Brandt, B. Moepps et al., Classification of Congenital Leptin Deficiency. J. Clin. Endocrinol. Metab. 109, 602\u20132616 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgae149","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4696_CR81","doi-asserted-by":"publisher","first-page":"2508188","DOI":"10.1080\/21623945.2025.2508188","volume":"14","author":"H Yupanqui-Lozno","year":"2025","unstructured":"H. Yupanqui-Lozno, J.A. Huertas-Quintero, M.E. Yupanqui-Velazco, R.A. Salinas-Osornio, C.M. Restrepo et al., One-year metreleptin in Colombian sisters with congenital leptin deficiency. Adipocyte. 14, 2508188 (2025). https:\/\/doi.org\/10.1080\/21623945.2025.2508188","journal-title":"Adipocyte"},{"key":"4696_CR82","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/children11020153","volume":"11","author":"K Kalinderi","year":"2024","unstructured":"K. Kalinderi, V. Goula, E. Sapountzi, V.R. Tsinopoulou, L. Fidani, Syndromic and Monogenic Obesity: New Opportunities Due to Genetic-Based Pharmacological Treatment. Children. 11, 153 (2024). https:\/\/doi.org\/10.3390\/children11020153","journal-title":"Children"},{"key":"4696_CR83","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1056\/NEJMoa063988","volume":"356","author":"IS Farooqi","year":"2007","unstructured":"I.S. Farooqi, T. Wangensteen, S. Collins, W. Kimber, G. Matarese et al., Clinical and Molecular Genetic Spectrum of Congenital Deficiency of the Leptin Receptor. N Engl. J. Med. 356, 237\u2013247 (2007). https:\/\/doi.org\/10.1056\/NEJMoa063988","journal-title":"N Engl. J. Med."},{"key":"4696_CR84","doi-asserted-by":"publisher","unstructured":"C. Chaves, T. Kay, J. Anselmo, Early onset obesity due to a mutation in the human leptin receptor gene. Endocrinol Diabetes Metab Case Rep. 2022, 21\u20130124 (2022). https:\/\/doi.org\/10.1530\/EDM-21-0124","DOI":"10.1530\/EDM-21-0124"},{"key":"4696_CR85","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","volume":"8","author":"K Cl\u00e9ment","year":"2020","unstructured":"K. Cl\u00e9ment, van den E. Akker, J. Argente, A. Bahm, W.K. Chung et al., Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 8, 960\u2013970 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(20)30364-8","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4696_CR86","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/509","volume":"19","author":"H Krude","year":"1998","unstructured":"H. Krude, H. Biebermann, W. Luck, R. Horn, G. Brabant et al., Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155\u2013157 (1998). https:\/\/doi.org\/10.1038\/509","journal-title":"Nat. Genet."},{"key":"4696_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s1043-2760(99)00213-1","volume":"11","author":"H Krude","year":"2000","unstructured":"H. Krude, A. Gr\u00fcters, Implications of proopiomelanocortin (POMC) mutations in humans: The POMC deficiency syndrome. Trends Endocrinol. Metab. 11, 15\u201322 (2000). https:\/\/doi.org\/10.1016\/s1043-2760(99)00213-1","journal-title":"Trends Endocrinol. Metab."},{"key":"4696_CR88","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1210\/en.2011-1822","volume":"153","author":"DD Israel","year":"2012","unstructured":"D.D. Israel, S. Sheffer-Babila, De C. Luca, Y.H. Jo, S.M. Liu et al., Effects of leptin and melanocortin signaling interactions on pubertal development and reproduction. Endocrinology. 153, 2408\u20132419 (2012). https:\/\/doi.org\/10.1210\/en.2011-1822","journal-title":"Endocrinology"},{"key":"4696_CR89","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S2213-8587(24)00273-0","volume":"13","author":"J Argente","year":"2025","unstructured":"J. Argente, C.F. Verge, U. Okorie, I. Fennoy, M.M. Kelsey et al., Setmelanotide in patients aged 2\u20135 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial. Lancet Diabetes Endocrinol. 13, 29\u201337 (2025). https:\/\/doi.org\/10.1016\/S2213-8587(24)00273-0","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4696_CR90","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa1512693","volume":"375","author":"P K\u00fchnen","year":"2016","unstructured":"P. K\u00fchnen, K. Cl\u00e9ment, S. Wiegand, O. Blankenstein, K. Gottesdiener et al., Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist. N Engl. J. Med. 375, 240\u2013246 (2016). https:\/\/doi.org\/10.1056\/NEJMoa1512693","journal-title":"N Engl. J. Med."},{"key":"4696_CR91","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMra1106700","volume":"365","author":"AW Artenstein","year":"2011","unstructured":"A.W. Artenstein, S.M. Opal, Proprotein Convertases in Health and Disease. N Engl. J. Med. 365, 2507\u20132518 (2011). https:\/\/doi.org\/10.1056\/NEJMra1106700","journal-title":"N Engl. J. Med."},{"key":"4696_CR92","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1210\/er.2015-1117","volume":"37","author":"P Stijnen","year":"2016","unstructured":"P. Stijnen, B. Ramos-Molina, S. O\u2019Rahilly, J.W.M. Creemers, PCSK1 Mutations and Human Endocrinopathies: From Obesity to Gastrointestinal Disorders. Endocr. Rev. 37, 347\u2013371 (2016). https:\/\/doi.org\/10.1210\/er.2015-1117","journal-title":"Endocr. Rev."},{"key":"4696_CR93","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.pmbts.2015.12.001","volume":"140","author":"B Ramos-Molina","year":"2016","unstructured":"B. Ramos-Molina, M.G. Martin, I. Lindberg, PCSK1 Variants and Human Obesity. Prog Mol. Biol. Transl Sci. 140, 47\u201374 (2016). https:\/\/doi.org\/10.1016\/bs.pmbts.2015.12.001","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"4696_CR94","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJMc2207442","volume":"387","author":"P K\u00fchnen","year":"2022","unstructured":"P. K\u00fchnen, K. Cl\u00e9ment, Long-Term, MC4R Agonist Treatment in POMC-Deficient Patients. N Engl. J. Med. 387, 852\u2013854 (2022). https:\/\/doi.org\/10.1056\/NEJMc2207442","journal-title":"N Engl. J. Med."},{"key":"4696_CR95","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1210\/jc.2005-1411","volume":"91","author":"C Lubrano-Berthelier","year":"2006","unstructured":"C. Lubrano-Berthelier, B. Dubern, J.M. Lacorte, F. Picard, A. Shapiro et al., Melanocortin 4 receptor mutations in a large cohort of severely obese adults: Prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J. Clin. Endocrinol. Metab. 91, 1811\u20131818 (2006). https:\/\/doi.org\/10.1210\/jc.2005-1411","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4696_CR96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ijo.2016.161","volume":"41","author":"H Vollbach","year":"2017","unstructured":"H. Vollbach, S. Brandt, G. Lahr, C. Denzer, Von J. Schnurbein et al., Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort. Int. J. Obes. 41, 13\u201322 (2017). https:\/\/doi.org\/10.1038\/ijo.2016.161","journal-title":"Int. J. Obes."},{"key":"4696_CR97","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/2404","volume":"20","author":"GSH Yeo","year":"1998","unstructured":"G.S.H. Yeo, I.S. Farooqi, S. Aminian, D.J. Halsall, R.G. Stanhope et al., A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111\u2013112 (1998). https:\/\/doi.org\/10.1038\/2404","journal-title":"Nat. Genet."},{"key":"4696_CR98","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa022050","volume":"348","author":"IS Farooqi","year":"2003","unstructured":"I.S. Farooqi, J.M. Keogh, G.S.H. Yeo, E.J. Lank, T. Cheetham et al., Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene. N Engl. J. Med. 348, 1085\u20131095 (2003). https:\/\/doi.org\/10.1056\/NEJMoa022050","journal-title":"N Engl. J. Med."},{"key":"4696_CR99","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1210\/er.2009-0037","volume":"31","author":"YX Tao","year":"2010","unstructured":"Y.X. Tao, The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology. Endocr. Rev. 31, 506\u2013543 (2010). https:\/\/doi.org\/10.1210\/er.2009-0037","journal-title":"Endocr. Rev."},{"key":"4696_CR100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cmet.2018.05.008","volume":"28","author":"EW Iepsen","year":"2018","unstructured":"E.W. Iepsen, J. Zhang, H.S. Thomsen, E.L. Hansen, M. Hollensted et al., Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist. Cell. Metab. 28, 23\u201332 (2018). https:\/\/doi.org\/10.1016\/j.cmet.2018.05.008","journal-title":"Cell. Metab."},{"key":"4696_CR101","doi-asserted-by":"publisher","first-page":"100006","DOI":"10.1016\/j.xcrm.2020.100006","volume":"1","author":"EW Iepsen","year":"2020","unstructured":"E.W. Iepsen, C.T. Have, S. Veedfald, S. Madsbad, J.J. Holst et al., GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report. Cell. Rep. Med. 1, 100006 (2020). https:\/\/doi.org\/10.1016\/j.xcrm.2020.100006","journal-title":"Cell. Rep. Med."},{"key":"4696_CR102","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1101\/gad.12.20.3264","volume":"12","author":"JL Michaud","year":"1998","unstructured":"J.L. Michaud, T. Rosenquist, N.R. May, C.M. Fan, Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. Genes Dev. 12, 3264\u20133275 (1998). https:\/\/doi.org\/10.1101\/gad.12.20.3264","journal-title":"Genes Dev."},{"key":"4696_CR103","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1172\/JCI68016","volume":"123","author":"S Ramachandrappa","year":"2013","unstructured":"S. Ramachandrappa, A. Raimondo, A.M.G. Cali, J.M. Keogh, E. Henning et al., Rare variants in single-minded 1 (SIM1) are associated with severe obesity. J. Clin. Invest. 123, 3042\u20133050 (2013). https:\/\/doi.org\/10.1172\/JCI68016","journal-title":"J. Clin. Invest."},{"key":"4696_CR104","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1172\/JCI68035","volume":"123","author":"A Bonnefond","year":"2013","unstructured":"A. Bonnefond, A. Raimondo, F. Stutzmann, M. Ghoussaini, S. Ramachandrappa et al., Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features. J. Clin. Invest. 123, 3037\u20133041 (2013). https:\/\/doi.org\/10.1172\/JCI68035","journal-title":"J. Clin. Invest."},{"key":"4696_CR105","doi-asserted-by":"publisher","unstructured":"R. Gonsalves, K. Aleck, D. Newbern, G. Shaibi, C. Kapadia et al., Severe early onset obesity and hypopituitarism in a child with a novel SIM1 gene mutation. Endocrinol Diabetes Metab Case Rep. 2020, 1\u20135 (2020). https:\/\/doi.org\/10.1530\/EDM-20-0042","DOI":"10.1530\/EDM-20-0042"},{"key":"4696_CR106","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/genes16050588","volume":"16","author":"G Luppino","year":"2025","unstructured":"G. Luppino, M. Wasniewska, M. Giordano, G. Pepe, L.A. Morabito et al., Cumulative Effects of Genetic Variants Detected in a Child with Early-Onset Non-Syndromic Obesity Due to SIM-1 Gene Mutation. Genes. 16, 588 (2025). https:\/\/doi.org\/10.3390\/genes16050588","journal-title":"Genes"},{"key":"4696_CR107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng.287","volume":"41","author":"CJ Willer","year":"2009","unstructured":"C.J. Willer, E.K. Speliotes, R.J.F. Loos, S. Li, C.M. Lindgren et al., Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 41, 25\u201334 (2009). https:\/\/doi.org\/10.1038\/ng.287","journal-title":"Nat. Genet."},{"key":"4696_CR108","doi-asserted-by":"publisher","first-page":"e36023","DOI":"10.1016\/j.heliyon.2024.e36023","volume":"10","author":"I Takahashi","year":"2024","unstructured":"I. Takahashi, H. Ohseto, F. Ueno, T. Oonuma, A. Narita et al., Genome-wide association study based on clustering by obesity-related variables uncovers a genetic architecture of obesity in the Japanese and the UK populations. Heliyon. 10, e36023 (2024). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36023","journal-title":"Heliyon"},{"key":"4696_CR109","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/cen.12428","volume":"81","author":"B Xi","year":"2014","unstructured":"B. Xi, F. Takeuchi, A. Meirhaeghe, N. Kato, J.C. Chambers et al., Associations of genetic variants in\/near body mass index-associated genes with type 2 diabetes: a systematic meta-analysis. Clin. Endocrinol. (Oxf). 81, 702\u2013710 (2014). https:\/\/doi.org\/10.1111\/cen.12428","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4696_CR110","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/oby.2009.159","volume":"17","author":"J Zhao","year":"2009","unstructured":"J. Zhao, J.P. Bradfield, M. Li, K. Wang, H. Zhang et al., The role of obesity-associated loci identified in genome-wide association studies in the determination of pediatric BMI. Obes. (Silver Spring). 17, 2254\u20132557 (2009). https:\/\/doi.org\/10.1038\/oby.2009.159","journal-title":"Obes. (Silver Spring)"},{"key":"4696_CR111","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1210\/jc.2008-0649","volume":"93","author":"AP Goldstone","year":"2008","unstructured":"A.P. Goldstone, A.J. Holland, B.P. Hauffa, A.C. Hokken-Koelega, M. Tauber, Recommendations for the diagnosis and management of Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 93, 4183\u20134197 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0649","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4696_CR112","doi-asserted-by":"publisher","first-page":"93","DOI":"10.33160\/yam.2024.05.010","volume":"67","author":"K Hanaki","year":"2024","unstructured":"K. Hanaki, T. Kinoshita, M. Fujimoto, Y. Sonoyama-Kawashima, S. Kanzaki et al., Alstr\u00f6m Syndrome: A Review Focusing on Its Diverse Clinical Manifestations and Their Etiology as a Ciliopathy. Yonago Acta Med. 67, 93\u201399 (2024). https:\/\/doi.org\/10.33160\/yam.2024.05.010","journal-title":"Yonago Acta Med."},{"key":"4696_CR113","doi-asserted-by":"publisher","first-page":"11005","DOI":"10.3390\/ijms231911005","volume":"23","author":"R Mahmoud","year":"2022","unstructured":"R. Mahmoud, V. Kimonis, M.G. Butler, Genetics of Obesity in Humans: A Clinical Review. Int. J. Mol. Sci. 23, 11005 (2022). https:\/\/doi.org\/10.3390\/ijms231911005","journal-title":"Int. J. Mol. Sci."},{"key":"4696_CR114","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/43185","volume":"387","author":"CT Montague","year":"1997","unstructured":"C.T. Montague, I.S. Farooqi, J.P. Whitehead, M.A. Soos, H. Rau et al., Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387, 903\u2013908 (1997). https:\/\/doi.org\/10.1038\/43185","journal-title":"Nature"},{"key":"4696_CR115","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/32911","volume":"392","author":"K Cl\u00e9ment","year":"1998","unstructured":"K. Cl\u00e9ment, C. Vaisse, N. Lahlou, S. Cabrol, V. Pelloux et al., A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392, 398\u2013401 (1998). https:\/\/doi.org\/10.1038\/32911","journal-title":"Nature"},{"key":"4696_CR116","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/509","volume":"19","author":"H Krude","year":"1998","unstructured":"H. Krude, H. Biebermann, W. Luck, R. Horn, G. Brabant et al., Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155\u2013157 (1998). https:\/\/doi.org\/10.1038\/509","journal-title":"Nat. Genet."},{"key":"4696_CR117","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ng0797-303","volume":"16","author":"RS Jackson","year":"1997","unstructured":"R.S. Jackson, J.W.M. Creemers, S. Ohagi, M.L. Raffin-Sanson, L. Sanders et al., Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16, 303\u2013306 (1997). https:\/\/doi.org\/10.1038\/ng0797-303","journal-title":"Nat. Genet."},{"key":"4696_CR118","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/2404","volume":"20","author":"GSH Yeo","year":"1998","unstructured":"G.S.H. Yeo, I.S. Farooqi, S. Aminian, D.J. Halsall, R.G. Stanhope et al., A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111\u2013112 (1998). https:\/\/doi.org\/10.1038\/2404","journal-title":"Nat. Genet."},{"key":"4696_CR119","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/2407","volume":"20","author":"C Vaisse","year":"1998","unstructured":"C. Vaisse, K. Clement, B. Guy-Grand, P. Froguel, A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20, 113\u2013114 (1998). https:\/\/doi.org\/10.1038\/2407","journal-title":"Nat. Genet."},{"key":"4696_CR120","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1755-8794-5-65","volume":"5","author":"AL Volckmar","year":"2012","unstructured":"A.L. Volckmar, F. Bolze, I. Jarick, N. Knoll, A. Scherag et al., Mutation screen in the GWAS derived obesity gene SH2B1 including functional analyses of detected variants. BMC Med. Genomics. 5, 65 (2012). https:\/\/doi.org\/10.1186\/1755-8794-5-65","journal-title":"BMC Med. Genomics"},{"key":"4696_CR121","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41591-019-0622-0","volume":"25","author":"M Baron","year":"2019","unstructured":"M. Baron, J. Maillet, M. Huyvaert, A. Dechaume, R. Boutry et al., Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension. Nat. Med. 25, 1733\u20131738 (2019). https:\/\/doi.org\/10.1038\/s41591-019-0622-0","journal-title":"Nat. Med."},{"key":"4696_CR122","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41591-019-0622-0","volume":"25","author":"M Baron","year":"2019","unstructured":"M. Baron, J. Maillet, M. Huyvaert, A. Dechaume, R. Boutry et al., Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension. Nat. Med. 25, 1733\u20131738 (2019). https:\/\/doi.org\/10.1038\/s41591-019-0622-0","journal-title":"Nat. Med."},{"key":"4696_CR123","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nn1336","volume":"7","author":"GSH Yeo","year":"2004","unstructured":"G.S.H. Yeo, C.C.C. Hung, J. Rochford, J. Keogh, J. Gray et al., A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 7, 1187\u20131189 (2004). https:\/\/doi.org\/10.1038\/nn1336","journal-title":"Nat. Neurosci."},{"key":"4696_CR124","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.ijo.0803390","volume":"31","author":"J Gray","year":"2007","unstructured":"J. Gray, G. Yeo, C. Hung, J. Keogh, P. Clayton et al., Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. Int. J. Obes. 31, 359\u2013364 (2007). https:\/\/doi.org\/10.1038\/sj.ijo.0803390","journal-title":"Int. J. Obes."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04696-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:02:22Z","timestamp":1783969342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04696-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4696"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04696-3","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"227"}}